A 35-year-old man was admitted because of significant hepatic dysfunction with mild splenomegaly and intra-abdominal lymphadenopathy of unknown cause. 
Introduction
Infectious mononucleosis (IM) due to primary EpsteinBarr virus (EBV) infection commonly affects young adults between 15 and 30 years of age (1) . Difficulties of initial diagnosis of IM in older individuals have been documented because of the rare occurrence, absence of typical IM manifestations such as lymphadenopathy, tonsillopharyngitis, lymphocytosis accompanied by atypical lymphocytes and heterophile-antibody (1) . On the other hand, other pathogenic microorganisms such as Toxoplasma or viruses such as cytomegalovirus (CMV), human herpesvirus 6 (HHV-6) and human immunodeficiency virus (HIV), also provoke heterophile antibody-negative IM-like symptoms (1, 2) . Further, it is also reported that EBV infection alters humoral immunity, i.e. infected B lymphocytes transform to proliferate indefinitely and secrete antibodies either to viral proteins or to host-cells (3) , and occasionally present multi-positive serological results for viruses including CMV, HHV-6, measles virus and rubella virus (4, 5) . These conditions make the prompt and correct diagnosis of EBV-induced IM problematic. We present here a patient who was atypical for IM with respect to age and the initial manifestations such as significant hepatic dysfunction, extensive intra-abdominal lymphadenopathy and dual positive immunoglobulin (Ig)M both to EBV and CMV. Diagnostic problems posed by older IM patients, the possible mechanism of double positive viral serological and the significance of enlarged intra-abdominal lymph nodes are also discussed.
Case Report
A 35-year-old previously healthy Japanese man presented in May 2002 because of malaise lasting for 7 days. The patient was afebrile at 36.8°C and the physical examination produced no unusual findings, not even superficial lymphadenopathy. (Fig. 1) . The patient was suspected of acute hepatitis or lymphoproliferative disease on admission. Liver dysfunction reached a peak on the fourth hospital day as indicated by AST 389 IU/l and ALT 685 IU/l. On the sixth hospital day, the patient first developed a fever to 38.6°C and a sore throat, while severe exudative tonsillopharyngitis, and cervical lymphadenopathy developed rapidly, which prompted us to suspect IM. The WBC count peaked at that time, but the differential count was normal (10,400/ l of WBC count with 31% neutrophils, 55% lymphocytes, 12% monocytes, 1% basophils and 1% atypical lymphocytes). On the eighth hospital day, IgM antibodies with dual positivity to the viral capsid antigen of EBV and CMV were detected in the serum obtained at admission. This made IM highly likely, but led to diagnostic confusion as to which virus was responsible for IM symptoms. IM symptoms and intra-abdominal lymphadenopathy subsided as the result of only supportive therapies. When the patient left our hospital on the sixteenth day, IgM-CMV had become indeterminate in contrast to the unchanged titer of IgM-EBV (Table 1) . About 3 months later, the patient was finally diagnosed as EBV-induced IM on the basis of seroconversion of Epstein-Barr nuclear antigen (EBNA)-IgG and persistent negative IgG-CMV. In this case, inactivated CMV, cultured with human cells, was used as the antigen for the detection of CMV-IgM by enzyme immunoassay.
Discussion
Initial diagnosis of IM in older individuals is often difficult, since easily recognized IM findings such as tonsillopharyngitis, cervical lymphadenopathy and absolute lymphocytosis accompanied by atypical lymphocytes and heterophile-antibody may be mild or absent (1, 6) as in the present case. These inconclusive findings can result in delayed appropriate diagnosis or highly disparate diagnosis such as active viral hepatitis, acute cholecystitis, obstructive jaundice, bronchopneumonia or malignant lymphoma (1, 6 ). The present patient was at first considered to have acute hepatitis of unknown origin or lymphoproliferative disease complicating liver injury, because these symptoms far from satisfied Sumaya's diagnostic criteria for IM (Table 2 ) (7) until exudative tonsillopharyngitis and cervical lymphadenopathy were detected on the sixth hospital day. In addition, significantly elevated hepatic enzymes, over five-fold the normal range (8) , and intra-abdominal lymphadenopathy (9) were not typical of IM. less frequently and in a milder form than in EBV-induced IM (3, 10), but these never become conclusive criteria for differentiation (2) . A positive heterophile test certainly is a helpful clue for the identification of EBV-induced IM, but it cannot always be used because of its low prevalence in older (1) or in Japanese people (11) . It took as long as three months to establish EBV-induced IM based on seroconversion to EBNA-IgG positivity and reduced CMV-IgM titer conjunction with persistently negative CMV-IgG. This case clearly illustrates the difficulties of the initial diagnosis for older IM patients because of concomitant abnormal humoral immunity as well as inconclusive IM symptoms. It should thus be noted that aged IM patients present atypical physical and laboratory findings such as prolonged fever without apparent cause, less peripheral lymphadenopathy or more elevated hepatic enzymes (1, 3) . Although, to our regret, we failed to determine CMV-DNA in the blood and urine, examination by means of amplification of viral nucleic acid (2, 8) is necessary to avoid a delay in diagnosis and the resultant redundant diagnostic procedures or treatments which increase costs (1), when multi-positive viral serologies are encountered in an IM patient.
Several mechanisms of the simultaneous appearance of IgM to CMV and EBV in IM patients have been proposed such as coinfection of EBV and CMV (2, 12), reactivation of latent EBV infection probably due to transient suppression of cellular immunity by CMV (5, 10, 12-15), selective stimulation of CMV-primed memory B cells by EBV antigen or by induced lymphokines with EBV infection (2, 5), polyclonal B cell stimulation by EBV (4, 5, 13) , and truly antigenic cross-reactivity among the herpes viruses including EBV and CMV (13, 15) . No detection of IgG-EBNA and CMV-IgG at admission serologically eliminates previous exposure to EBV and CMV, thus excluding either viral reactivation or existence of primed B cells. Both the elimination of CMV infection by a transient increase in IgM followed by persistent absence of IgG, and confirmation of EBV infection by seroconversion of IgG-EBNA, suggest the CMV-IgM test result was false positive. Glycine-alanine-rich elements in EBNA-1 protein (2, 13) and glycine-rich motifs within the non-structural CMV protein of pUL44 and pUL55 are widely used as diagnostic antigens (2) . Since cross-reaction to major antigenic epitopes between these elements and motifs have been demonstrated to be a cause of false positive IgM-CMV results, it is tempting to speculate that induced EBV-IgM also recognized the CMV protein in the present case. However, careful interpretation of this finding in combination with IgM-EBV, IgM-CMV, IgG-EBNA and IgG-CMV is essential for a diagnosis of a patient with IM symptoms (15) , since IgM-CMV induced by CMV infection adversely cross-reacts with EBNA-1 protein (2, 14) . Inconsistent false positive rates of IgM-CMV in IM patients ranging from 20.4% (10) to 40.9% (15) , depend probably upon the specificity of kits, i.e. the antigenic CMV protein employed.
In contrast to cervical lymphadenopathy or splenomegaly, little has been published about deep-seated, i.e. intraabdominal, lymphadenopathy in IM (9) . In the case of viral or immune-mediated liver disease, enlargement of perihepatic (9, 16) , peripancreatic (17) or retroperitoneal (18) lymph nodes represents activity of regional inflammation and/or immune response of the host, such as viral replication within the liver, direct spread of the hepatic inflammatory process, or recruitment of infected lymphocytes and/or macrophages to draining lymph nodes (16, 18) . In the case of EBV infection, proliferation of lymphocytes and/or production of immunoglobulin may be added to the definition of lymphadenopathy because of the lymphotropic nature of EBV and its potent B-cell stimulating action (3). In the present case, intra-abdominal lymphadenopathy and hepatic dysfunction completely preceded over tonsillopharyngitis and cervical lymphadenopathy, and the peak values of transaminases were unusually high for IM-related liver injury. In view of these clinical observations, the possibility cannot be entirely excluded that EBV may have replicated in an unusual manner such as in the liver as well as the oropharyngeal epithelium, or that intra-abdominal lymphadenopathy may serve as a marker for activity of hepatic involvement or systemic immunological alterations (18) . These changes include enhanced production of immunoglobulin leading to false positive serologies or complication of autoimmune diseases (3). Needless to say, further studies are necessary to clarify the relationship between intra-abdominal lymph nodes and IM manifestations, hepatic involvement and alterations in the immune system. However, more attention should be also directed to intra-abdominal lymph nodes, when splenomegaly or liver injury is evaluated by means of US or CT in IM patients. at least 50% or 5,000 lymphocytes/ l and at least 10% or 1,000 atypical lymphocytes/ l
